Viewing nowElosuva Tablet 10 mg (Rosuvastatin Calcium (Unprocessed))
Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Joongheon Pharmaceutical Co., Ltd.

MFDS item code 201400402 · Approved 2014.01.29 · Insurance code 053300640
Treatment of dyslipidemia, inhibition of atherosclerosis progression, reduction of cardiovascular disease risk
This medication is used as an adjunct to diet and exercise in patients with primary hypercholesterolemia and mixed dyslipidemia when these measures are inadequate. It is also used in patients with homozygous familial hypercholesterolemia to help lower cholesterol levels in conjunction with diet or other lipid-lowering therapies. In patients with hypercholesterolemia, it reduces total cholesterol and LDL cholesterol, thereby delaying the progression of atherosclerosis. In pediatric patients with heterozygous familial hypercholesterolemia, it is also used as an adjunct to diet to reduce cholesterol levels. It is utilized as an adjunct to diet in patients with primary dysbetalipoproteinemia as well. Additionally, this medication contributes to the reduction of risks associated with stroke, myocardial infarction, and arterial revascularization procedures in certain high-risk groups. Therefore, this medication is effectively used for the treatment and risk reduction of various conditions related to hypercholesterolemia.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this drug is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to patients with certain allergies. It should also not be given to patients with severe liver dysfunction or unexplained elevations in liver enzymes. Patients with muscle disorders or muscle damage, and those taking cyclosporine, a specific immunosuppressant, should not use this medication. Patients with significantly reduced kidney function and women who are pregnant, breastfeeding, or of childbearing potential should consult a physician before taking this medication. In particular, high-dose administration is prohibited for patients at high risk of muscle disorders. Additionally, this medication contains lactose and should not be administered to patients with lactose intolerance or related genetic disorders. Caution is warranted for patients who have a history of excessive alcohol consumption or liver disease, and regular liver function tests should be conducted before and during treatment. If symptoms such as muscle pain or weakness occur, the physician should be notified immediately, and in severe cases, the medication should be discontinued. Additionally, caution is needed for patients with impaired renal function or hypothyroidism, elderly patients, and those with alcohol abuse, as they are at higher risk for muscle-related side effects. This medication may interact with certain drugs; patients taking other medications should inform their healthcare provider. In particular, the risk of muscle side effects may increase when used in combination with certain antiviral agents, immunosuppressants, antifungal agents, antibiotics, and fibric acid derivatives. During pregnancy, it may be harmful to the fetus, so proper contraception must be practiced, and women who are pregnant or planning to become pregnant should not use this medication. Nursing mothers should also avoid taking this medication, and if pregnancy is confirmed during treatment, it must be discontinued immediately. There are no specific antidotes for overdose, so treatment should be symptomatic along with liver and muscle function tests. This medication does not significantly affect driving or machine operation, but dizziness may occur, so caution is advised. Regular checks of liver and muscle health during treatment are important.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated with drug reaction syndrome, fixed drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that does not allow air or moisture to enter. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.
Pink round film-coated tablet
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Joongheon Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.